Ernexa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.18	1.88	1.73	7.58	11.45	16.99
Cash & Short-Term Investments	9.18	1.88	1.73	7.58	11.45	16.99
Cash Growth	378.47%	8.96%	-77.18%	-33.82%	-32.61%	942.02%
Other Receivables	0.1	0.85	0.44	0.43	0.95	0.68
Total Trade Receivables	0.1	0.85	0.44	0.43	0.95	0.68
Other Current Assets	0.72	0.4	0.19	1.6	1.28	1.1
Total Current Assets	10	3.13	2.35	9.6	13.68	18.77
Net Property, Plant & Equipment	0.44	0.55	0.76	33.27	1.27	3.24
Goodwill	-	2.04	2.04	2.04	2.04	2.04
Long-Term Investments	-	-	-	-	0.06	1
Other Long-Term Assets	0.11	0.11	0.12	4.22	5.23	6.48
Total Assets	10.54	5.83	5.27	49.13	22.28	31.53
Accounts Payable	1.3	1.13	1.72	1.07	1.62	1.76
Accrued Expenses	1.48	0.9	1.01	1.89	3.63	1.25
Current Portion of Leases	0.16	0.21	0.21	2.22	0.3	0.43
Unearned Revenue	-	-	-	0.19	-	-
Other Current Liabilities	0.51	0.88	0	1.31	2.11	0.25
Total Current Liabilities	3.46	3.11	2.94	6.57	7.65	3.68
Long-Term Debt	-	-	-	6.77	-	-
Long-Term Leases	0.23	0.28	0.48	32.85	0.89	2.3
Other Long-Term Liabilities	0	0.04	0.15	0.59	1.63	0.05
Total Long-Term Liabilities	0.23	0.32	0.63	40.22	2.52	2.35
Total Liabilities	3.68	3.43	3.57	46.9	10.17	6.02
Preferred Stock	0	0	0	0	0	0
Common Stock	0.01	0.04	0.02	0.03	0.03	0.01
Additional Paid-in Capital	257.99	248	233.22	189.19	177.38	166.19
Retained Earnings	-251.14	-245.64	-231.54	-186.98	-165.3	-140.7
Shareholders' Equity	6.86	2.4	1.7	2.23	12.11	25.5
Total Liabilities & Equity	10.54	5.83	5.27	49.13	22.28	31.53
Total Debt	0.39	0.49	0.68	41.84	1.18	2.72
Net Cash (Debt)	8.79	1.39	1.05	-34.27	10.26	14.26
Net Cash Growth	530.42%	33.40%	-	-	-28.03%	-
Net Cash Per Share	21.20	5.53	28.71	-2420.06	1261.55	2470.32
Book Value	6.86	2.4	1.7	2.23	12.11	25.5
Book Value Per Share	16.54	9.52	46.73	157.70	1488.08	4417.38
Tangible Book Value	6.86	0.36	-0.34	0.19	10.06	23.46
Tangible Book Value Per Share	16.54	1.42	-9.42	13.35	1236.85	4063.34

SEC Filings: 10-K · 10-Q